Copyright: ©Author(s) 2026.
World J Hepatol. Jun 27, 2026; 18(6): 120213
Published online Jun 27, 2026. doi: 10.4254/wjh.120213
Published online Jun 27, 2026. doi: 10.4254/wjh.120213
Table 3 Recurrence risk according to the number of pre-operative risk factors (cirrhosis, albumin-bilirubin grade ≥ 2, Barcelona Clinic Liver Cancer staging system stage B/C)
| Number of risk factors | Criteria present | aHR (95%CI) | P value | n (%) |
| 0 | None | Reference | Reference | 60 (26) |
| 1 | Any one of: Cirrhosis, ALBI ≥ 2, or BCLC stage B/C | 2.74 (1.57-4.76) | < 0.001 | 102 (43) |
| 2 | Any two | 4.32 (2.29-8.12) | < 0.001 | 62 (26) |
| 3 | All three | 7.53 (2.47-22.93) | < 0.001 | 10 (4) |
- Citation: Blackmore C, Lockart I, Gandy G, Yeoh YKJ, Flynn C, Prince DS, Dore G, Danta M, George J, Alavi M, Farooque Y, Hajarizadeh B, Levy MT. Recurrence after surgery for hepatocellular carcinoma: “The seed and the soil” - a multicentre retrospective cohort study. World J Hepatol 2026; 18(6): 120213
- URL: https://www.wjgnet.com/1948-5182/full/v18/i6/120213.htm
- DOI: https://dx.doi.org/10.4254/wjh.120213